GW1929
CAS: 196808-24-9
Ref. 3D-WHA80824
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Informação sobre produto
- (S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)phenyl)propanoic acid
- <span class="text-smallcaps">L</span>-Tyrosine, N-(2-benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-
- Gw-1929
- N-(2-Benzoylphenyl)-O-[2-(methyl-2-pyridinylamino)ethyl]-<span class="text-smallcaps">L</span>-tyrosine
- N-(2-Benzoyphenyl)-O-[2-[N-methyl-N-(2-pyridinyl)amino]ethyl]-L-tyrosine
- O-{2-[methyl(pyridin-2-yl)amino]ethyl}-N-[2-(phenylcarbonyl)phenyl]-L-tyrosine
GW1929 is a drug that inhibits the production of prostaglandin J2 and hence has anti-inflammatory properties. It also blocks voltage-dependent calcium channels, which are involved in the propagation of pain signals. GW1929 is an agonist for PPARγ, which regulates transcriptional factors. It can be used for the treatment of cancer in humans and animals. GW1929 has been shown to block signal pathways involved in the development of cancer cells and to inhibit tumor formation in rodents. In addition, it has been shown to have an effect on body weight, energy metabolism, and cellular differentiation. The drug also inhibits mitochondrial membrane potential and pparγ expression in rat adipocytes.
Propriedades químicas
Consulta técnica sobre: 3D-WHA80824 GW1929
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.